Herpes zóster en lactantes. Presentación de tres casos / Herpes zoster in infants. Three cases report

RESUMEN El herpes zóster es una afección infrecuente en lactantes, con una incidencia de 0,74/1 000 habitantes. Se produce por la reactivación del virus de la varicela zóster, tras una primoinfección por varicela. Puede ocurrir intraútero, por lo que resulta relevante conocer los antecedentes maternos. El diagnóstico es clínico y si se realiza de forma adecuada reduce el riesgo de complicaciones. El tratamiento en los niños es sintomático, porque su evolución es más favorable que en los adultos. Debido a la rareza de esta entidad, se presentan tres casos de herpes zóster en lactantes de 4, 6 y 11 meses de edad, que acudieron con lesiones y evolución típica de esta enfermedad al Hospital Pediátrico Provincial Docente Eliseo Noel Caamaño, de Matanzas, entre septiembre y octubre de 2017 (AU).

ABSTRACT Herpes zoster is an uncommon affection in infants, with an incidence of 0.74/1 000 inhabitants. It is produced by the reactivation of the varicella-zoster virus, after a primary infection by varicella. This can occur inside the uterus, making it relevant to know maternal antecedents. The diagnosis is clinical, and if it is made in an appropriate way, reduces complication risk. The treatment in children is symptomatic because its evolution is more favorable than in adults. Due to the rareness of this entity, we present three cases of herpes zoster in nurslings aged 4, 6 and 11 moths who assisted the Teaching Pediatric Hospital Eliseo Noel Caamaño, of Matanzas, with lesions and typical evolution of this disease in the period September-October 2017 (AU).

Are there synergistic or antagonistic effects of multiple maternally derived egg components on offspring phenotype?

Eggs are 'multivariate' in that they contain multiple maternally derived egg components (e.g. hormones, antibodies, mRNA, antioxidants) which are thought to influence offspring phenotype. However, most studies have focused on single egg components and on short-term effects. Here, we simultaneously manipulated two egg components, maternally derived antibodies (MAb) and yolk testosterone, to assess potential synergistic or antagonistic effects on zebra finch offspring phenotype from hatching to sexual maturity. We found no evidence for short- or long-term effects of either MAb or yolk testosterone alone, or their interaction, on hatching mass, size at fledging (tarsus length), body mass at sexual maturity (day 82), chick survival, humoral immune function or any measured female reproductive trait at sexual maturity. There was a positive effect of yolk testosterone, but not MAb, on offspring phytohaemagglutinin (PHA) response at 26 days of age but at 82 days of age, MAb, but not yolk testosterone, had a positive effect on PHA response. There was also a MAb×sex interaction on 30 day chick mass, and a positive effect of yolk testosterone on male courtship behaviour at sexual maturity. However, we found no evidence for synergy, i.e. where offspring treated with both MAb and yolk testosterone had higher trait values than offspring treated with either MAb or yolk testosterone alone for any measured trait. Similarly, evidence for antagonistic (compensatory) effects, where offspring treated with both MAb and yolk testosterone had intermediate trait values compared with offspring treated with either MAb or yolk testosterone alone, was equivocal.